MedTrace Logo

Genetic Characterization of Patients With Arrhythmia-Induced Cardiomyopathy

NCT06896266 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 109

Last updated 2025-05-14

No results posted yet for this study

Summary

The goal of this observational study is to learn about the genetic insights of arrhythmya-induced cardiomyopathy and its clinical prognosis. The main questions it aims to answer are:

I. Does patients with arrhythmia-induced cardiomyopathy have a greater proportion of genetic mutations compared with other types of cardiomyopathy or general population? II. Have the genetics any prognostic impact in patients with arrhythmia-induced cardiomyopathy?

Conditions

Sponsors & Collaborators

  • Hospital Universitario 12 de Octubre

    lead OTHER

Principal Investigators

  • Martín Negreira-Caamaño, MD, PhD · Cardiology department, 12 de Octubre University Hospital

  • Rafael Salguero-Bodes, MD · Cardiology Department, 12 de Octubre University Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-12-01
Primary Completion
2025-12-31
Completion
2026-12-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06896266 on ClinicalTrials.gov